Alnylam Pharmaceuticals Inc - Company Profile
Powered by 
All the sales intelligence you need on Alnylam Pharmaceuticals Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Alnylam Pharmaceuticals Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Alnylam Pharmaceuticals Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Related keylists
Alnylam Pharmaceuticals Catalyst Calendar
Proactively evaluate Alnylam Pharmaceuticals Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
A sample of Alnylam Pharmaceuticals Catalyst Calendar data
| Event Date | Event Type | Company Name | Ticker Symbol | Drug Name | Therapy Area | Indication | Source Type |
|---|---|---|---|---|---|---|---|
| 01 Oct 2019 | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Lorem |
| 30 Sep 2019 | Phase III Trial Results | Alnylam Pharmaceuticals Inc; The Medicines Co | ALNY | inclisiran | Cardiovascular; Metabolic Disorders | Atherosclerosis; Cardiovascular Disease; Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) | Company Press Release |
| 01 Sep 2019 | Phase III Trial Results | Alnylam Pharmaceuticals Inc; The Medicines Co | ALNY | inclisiran | Cardiovascular; Metabolic Disorders | Atherosclerosis; Cardiovascular Disease; Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) | Company Presentation |
| 01 Sep 2019 | Phase III Trial Results | Alnylam Pharmaceuticals Inc; PPD Inc; The Medicines Co | ALNY | inclisiran | Cardiovascular; Metabolic Disorders | Atherosclerosis; Cardiovascular Disease; Cardiovascular Risk Factors; Coronary Artery Disease (CAD) (Ischemic Heart Disease); Familial Hypercholesterolemia (Type II Hyperlipoproteinemia); Hypercholesterolemia; Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD); Type 2 Diabetes | Company Presentation |
Feature
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
Benefit
Access:
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Value
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer